The Senate Health and Human Services Committee will reconsider a bill that regulates cannabidiol, or CBD, a Schedule IV drug in South Dakota.
That means CBD is available only by prescription.
Opponents to Senate Bill 22 say it criminalizes hemp CBD and prevents the state from exploring hemp as a crop. SDPB's Victoria Wicks has this report.
Credit Pat Cromwell
